Literatur:
Pfreundschuh MG et al. Lancet Oncol. 2006;7(5):379-91
Stephens DM. et al. J Clin Oncol. 2016;34(25):2997-3004
Persky DO et al. Blood. 2015;125(2):236-41
Sehn LH et al. Annals of Oncol. 2011;22(Suppl_4):Iv91
Jais JP et al. Haematologica. 2017;102(10):e404-e406
Poeschel V et al. Blood. 2018;132(Suppl_1):781
Persky D et al. Blood. 2019;134(Suppl_1):349
Poeschel V. et al. Lancet. Lancet. 2020;394(10216):2271-81
Stephens DM et al. J Clin Oncol. 2016;34(25):2997-3004
Sehn LH et al. Blood. 2019;134 (Supp_1):401
Mamot C et al. J Clin Oncol. 2015;33(23):2523-9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krasniqi, F., Stenner, F. PET/CT-gesteuerte Therapie im Stadium I/II. InFo Hämatol Onkol 23, 22–23 (2020). https://doi.org/10.1007/s15004-020-8099-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-020-8099-z